Dublin, Nov. 07, 2024 (GLOBE NEWSWIRE) -- The "Kidney Stone Management Market Report and Forecast 2024-2032" report has been added to ResearchAndMarkets.com's offering.
The global market size for kidney stone management reached a value of USD 1.80 billion in 2023. The market is expected to grow at a CAGR of 5.20% between 2024-2032 and attain a value of USD 2.84 billion by 2032.
Increasing prevalence of kidney stones, technological advancements in treatment options, and rising awareness about kidney health are pivotal factors influencing the market's growth.
North America leads the market due to high healthcare expenditure and advanced medical infrastructure. Europe follows, driven by technological advancements and increasing kidney stone prevalence. Asia-Pacific is poised for significant growth, propelled by expanding healthcare infrastructure, rising awareness, and increasing disposable incomes. Latin America and the Middle East and Africa are emerging markets with growth driven by improving healthcare access and rising prevalence of kidney stones. Future growth across all regions will be bolstered by technological innovations and increased awareness of kidney health.
The competitive landscape of the global kidney stone management market features prominent players such as Cook Group Incorporated, Richard Wolf GmbH, Boston Scientific Corporation, Dornier MedTech GmbH, Olympus Corporation, and KARL STORZ SE & Co. KG. These companies are actively engaged in mergers and acquisitions to expand their market presence and technological capabilities.
Significant investments in research initiatives focus on developing advanced, minimally invasive treatment options. New product introductions, such as state-of-the-art lithotripters and ureterorenoscopes, are frequent to meet the rising demand for effective kidney stone management. Additionally, strategic partnerships and collaborations are common to enhance product portfolios and strengthen global distribution networks.
Market Drivers
Several key drivers are propelling the global kidney stone management market forward:
- Increasing Incidence of Kidney Stones: Rising prevalence of kidney stones due to dietary changes, lifestyle factors, and higher rates of obesity are driving the demand for effective management solutions. An ageing population also contributes to the increased incidence of kidney stones.
- Technological Advancements: Continuous advancements in medical technology have led to the development of minimally invasive and non-invasive treatment options. Innovations such as extracorporeal shock wave lithotripsy (ESWL) and advanced ureteroscopy techniques enhance treatment efficacy and patient comfort.
- Awareness and Screening Programs: Growing awareness about kidney stone prevention and management, coupled with increased screening programmes, is driving early diagnosis and treatment. Health campaigns and educational initiatives are helping patients recognise symptoms and seek timely medical intervention.
- Rising Healthcare Expenditure: Increased healthcare spending in both developed and emerging economies facilitates better access to advanced kidney stone management treatments. Governments and private healthcare providers are investing in state-of-the-art medical infrastructure.
- Pharmaceutical Innovations: Development of new medications to dissolve kidney stones and prevent their recurrence is expanding the pharmaceutical segment of the market. These innovations provide non-invasive options for patients who prefer medication over surgical interventions.
Market Challenges
Despite the positive growth outlook, the global kidney stone management market faces several challenges:
- High Treatment Costs: The cost of advanced treatment options, such as laser lithotripsy and robotic-assisted surgeries, can be prohibitive for many patients. High out-of-pocket expenses and limited insurance coverage in some regions hinder market growth.
- Complications and Recurrence: Although modern treatments are effective, complications such as infections and the recurrence of kidney stones remain significant challenges. Patients often require ongoing management and monitoring, which can be burdensome.
- Lack of Awareness in Developing Regions: In many developing countries, there is a lack of awareness about kidney stone prevention and management. Limited access to healthcare facilities and diagnostic services further exacerbates the problem, restricting market expansion in these areas.
- Regulatory Hurdles: Stringent regulatory requirements for the approval of new devices and drugs can delay the introduction of innovative treatments. Compliance with diverse regulatory standards across different regions adds complexity to market entry and product distribution.
Future Opportunities
The future of the global kidney stone management market holds promising opportunities:
- Emerging Markets: Expanding healthcare infrastructure and rising disposable incomes in emerging markets present significant growth opportunities. Increasing healthcare investments in countries such as China, India, and Brazil are expected to boost market penetration.
- Personalised Medicine: Advances in genetic research and personalised medicine are paving the way for tailored treatment approaches. Customised therapies based on individual patient profiles can enhance treatment outcomes and reduce recurrence rates.
- Telemedicine and Remote Monitoring: Integration of telemedicine and remote monitoring technologies can improve patient management and follow-up care. Remote consultations and digital health platforms enable continuous monitoring and timely intervention, especially in remote or underserved areas.
- Research and Development: Ongoing research into novel treatment modalities, including nanotechnology and regenerative medicine, holds potential for groundbreaking advancements in kidney stone management. Investment in R&D will drive the development of more effective and less invasive treatment options.
- Preventive Healthcare: Increasing emphasis on preventive healthcare and lifestyle modifications can reduce the incidence of kidney stones. Public health initiatives focused on promoting healthy diets, hydration, and regular medical check-ups will play a crucial role in mitigating the burden of kidney stones.
Key Benefits for Stakeholders
- The industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the global kidney stone management market from 2017-2032.
- The research report provides the latest information on the market drivers, challenges, and opportunities in the kidney stone management market.
- The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
- Porter's five forces analysis assists stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the global kidney stone management industry and its attractiveness.
- The competitive landscape allows stakeholders to understand their competitive environment and provides insight into the current positions of key players in the market.
Key Attributes
| Report Attribute | Details |
| No. of Pages | 200 |
| Forecast Period | 2024-2032 |
| Estimated Market Value (USD) in 2024 | $1.89 Billion |
| Forecasted Market Value (USD) by 2032 | $2.84 Billion |
| Compound Annual Growth Rate | 5.2% |
| Regions Covered | Global |
Key Topics Covered
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Kidney Stone Management Market Overview
3.1 Global Kidney Stone Management Market Historical Value (2017-2023)
3.2 Global Kidney Stone Management Market Forecast Value (2024-2032)
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 Global Kidney Stone Management Market Landscape*
5.1 Global Kidney Stone Management: Developers Landscape
5.1.1 Analysis by Year of Establishment
5.1.2 Analysis by Company Size
5.1.3 Analysis by Region
5.2 Global Kidney Stone Management: Product Landscape
5.2.1 Analysis by Product Type
6 Global Kidney Stone Epidemiology Snapshot
6.1 Global Kidney Stone Incidence Number Overview (2017 - 2032)
6.2 Global Kidney Stone Incidence - by Disease (2017 - 2032)
7 Global Kidney Stone Management Market Dynamics
7.1 Market Drivers and Constraints
7.2 SWOT Analysis
7.3 PESTEL Analysis
7.4 Porter's Five Forces Model
7.5 Key Demand Indicators
7.6 Key Price Indicators
7.7 Industry Events, Initiatives, and Trends
7.8 Value Chain Analysis
8 Global Kidney Stone Management Market: Trade Data Analysis (HS Code- 90189097)
8.1 Major Exporting Countries
8.2 Major Importing Countries
9 Global Kidney Stone Management Market Segmentation (2017-2032)
9.1 Global Kidney Stone Management Market (2017-2032) by Product Type
9.2 Global Kidney Stone Management Market (2017-2032) by Treatment
9.3 Global Kidney Stone Management Market (2017-2032) by End User
9.4 Global Kidney Stone Management Market (2017-2032) by Region
10 North America Kidney Stone Management Market (2017-2032)
11 Europe Kidney Stone Management Market (2017-2032)
12 Asia-Pacific Kidney Stone Management Market (2017-2032)
13 Latin America Kidney Stone Management Market (2017-2032)
14 Middle East and Africa Kidney Stone Management Market (2017-2032)
15 Regulatory Framework
15.1 Regulatory Overview
15.2 US FDA
15.3 EU EMA
15.4 INDIA CDSCO
15.5 JAPAN PMDA
15.6 Others
16 Patent Analysis
16.1 Analysis by Type of Patent
16.2 Analysis by Publication Year
16.3 Analysis by Issuing Authority
16.4 Analysis by Patent Age
16.5 Analysis by CPC Analysis
16.6 Analysis by Patent Valuation
16.7 Analysis by Key Players
17 Strategic Initiatives
17.1 Analysis by Partnership Instances
17.2 Analysis by Type of Partnership
17.3 Analysis by Leading Players
17.4 Analysis by Geography
18 Supplier Landscape
18.1 Market Share Analysis, by Region (Top 5 Companies)
18.2 Cook Group Incorporated
18.3 Richard Wolf GmbH
18.4 Boston Scientific Corporation
18.5 Dornier MedTech GmbH
18.6 Olympus Corporation
18.7 KARL STORZ SE & Co. KG
19 Global Kidney Stone Management Market - Distribution Model
19.1 Overview
19.2 Potential Distributors
19.3 Key Parameters for Distribution Partner Assessment
20 Key Opinion Leaders (KOL) Insights
For more information about this report visit https://www.researchandmarkets.com/r/r2iq8b
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
